{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:49:44Z","timestamp":1761749384469,"version":"build-2065373602"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.path.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T17:23:28Z","timestamp":1588872208000},"page":"291-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular Advances in Central Nervous System Mesenchymal Tumors"],"prefix":"10.1016","volume":"13","author":[{"given":"Jeffrey","family":"Helgager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Driver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl_4","key":"10.1016\/j.path.2020.02.002_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.path.2020.02.002_bib2","series-title":"World Health Organization classification of tumours","first-page":"408","article-title":"WHO classification of tumours of the central nervous system","author":"Louis","year":"2016"},{"key":"10.1016\/j.path.2020.02.002_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.1982.tb50361.x","article-title":"The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935-1977","volume":"381","author":"Kurland","year":"1982","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib4","first-page":"586","article-title":"Epidemiology of primary intracranial neoplasms in Manitoba, Canada","volume":"14","author":"Sutherland","year":"1987","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/2015.6.JNS15591","article-title":"Genomic landscape of intracranial meningiomas","volume":"125","author":"Bi","year":"2016","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-013-1104-y","article-title":"Hand in glove: brain and skull in development and dysmorphogenesis","volume":"125","author":"Richtsmeier","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"20","key":"10.1016\/j.path.2020.02.002_bib7","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2010.609","article-title":"Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes","volume":"30","author":"Kalamarides","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijrobp.2009.11.032","article-title":"Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy","volume":"79","author":"Tanzler","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/neuonc\/nos013","article-title":"Impaired survival and long-term neurological problems in benign meningioma","volume":"14","author":"van Alkemade","year":"2012","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","article-title":"WHO grade II and III meningiomas: a study of prognostic factors","volume":"95","author":"Durand","year":"2009","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","article-title":"Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection","volume":"75","author":"Sun","year":"2014","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","article-title":"Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection","volume":"75","author":"Sun","year":"2014","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases","volume":"86","author":"Palma","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.path.2020.02.002_bib15","series-title":"Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumours","first-page":"314","author":"Kleihues","year":"2000"},{"key":"10.1016\/j.path.2020.02.002_bib16","series-title":"WHO classification of tumours of the central nervous system. World Health Organization classification of tumours","first-page":"309","author":"Louis","year":"2007"},{"issue":"12","key":"10.1016\/j.path.2020.02.002_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","article-title":"Meningioma grading: an analysis of histologic parameters","volume":"21","author":"Perry","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jnen\/nlv006","article-title":"Meningiomas with rhabdoid features lacking other histologic features of malignancy: a study of 44 cases and review of the literature","volume":"75","author":"Vaubel","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.path.2020.02.002_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/01.WNL.0000138569.45818.50","article-title":"Natural history of conservatively treated meningiomas","volume":"63","author":"Herscovici","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2020.02.002_bib21","first-page":"679480","article-title":"Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors","author":"Patel","year":"2019","journal-title":"bioRxiv"},{"issue":"13","key":"10.1016\/j.path.2020.02.002_bib22","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","article-title":"Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation","volume":"22","author":"Vasudevan","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib23","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1038\/s41598-018-31659-0","article-title":"An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures","volume":"8","author":"Collord","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/neuonc\/nov177","article-title":"A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma","volume":"18","author":"Aizer","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.path.2020.02.002_bib26","article-title":"Genomic landscape of high-grade meningiomas","volume":"2","author":"Bi","year":"2017","journal-title":"NPJ Genom Med"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","article-title":"Genomic landscape of meningiomas","volume":"20","author":"Lee","year":"2010","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J Neurooncol"},{"issue":"10","key":"10.1016\/j.path.2020.02.002_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat Genet"},{"issue":"3\u20134","key":"10.1016\/j.path.2020.02.002_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000056986","article-title":"Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases","volume":"93","author":"Zang","year":"2001","journal-title":"Cytogenet Cell Genet"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.path.2020.02.002_bib32","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.18632\/oncotarget.2517","article-title":"Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5","volume":"5","author":"Abedalthagafi","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Lamszus","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostrom","year":"2001","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/FVNU-7UBY-DXE3-77MT","article-title":"PS6K amplification characterizes a small subset of anaplastic meningiomas","volume":"115","author":"Cai","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.13135","article-title":"SMARCE1 mutation screening in classification of clear cell meningiomas","volume":"70","author":"Smith","year":"2017","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<270::AID-GCC14>3.0.CO;2-W","article-title":"Unbalanced translocation t(1;3)(p12-13;q11) in meningiomas as the unique feature of chordoid differentiation","volume":"26","author":"Steilen-Gimbel","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib41","first-page":"535","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.path.2020.02.002_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","article-title":"BAP1 mutations in high-grade meningioma: implications for patient care","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.path.2020.02.002_bib43","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.path.2020.02.002_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1789.2011.01201.x","article-title":"Rhabdoid papillary meningioma: a clinicopathologic case series study","volume":"31","author":"Wu","year":"2011","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","article-title":"TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas","volume":"139","author":"Biczok","year":"2018","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41467-017-00174-7","article-title":"Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas","volume":"8","author":"Agnihotri","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2020.02.002_bib49","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1038\/ncomms14433","article-title":"Integrated genomic analyses of de novo pathways underlying atypical meningiomas","volume":"8","author":"Harmanci","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2020.02.002_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1749-6632.1991.tb37776.x","article-title":"Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma)","volume":"615","author":"Fontaine","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.path.2020.02.002_bib51","first-page":"1022","article-title":"Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas","volume":"54","author":"Lekanne Deprez","year":"1994","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib52","first-page":"827","article-title":"Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma","volume":"146","author":"Wellenreuther","year":"1995","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1750-3639.2006.tb00557.x","article-title":"NF2 mutations in secretory and other rare variants of meningiomas","volume":"16","author":"Hartmann","year":"2006","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.909","article-title":"NF2 status of meningiomas is associated with tumour localization and histology","volume":"194","author":"Kros","year":"2001","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.path.2020.02.002_bib55","first-page":"2046","article-title":"\"Malignancy\" in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Perry","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"issue":"6123","key":"10.1016\/j.path.2020.02.002_bib57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","article-title":"AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry","volume":"126","author":"Sahm","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.path.2020.02.002_bib60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","volume":"48","author":"Clark","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","article-title":"Mutation of the PIK3CA oncogene in human cancers","volume":"94","author":"Karakas","year":"2006","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","article-title":"Genetic landscape of meningioma","volume":"33","author":"Yuzawa","year":"2016","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib64","doi-asserted-by":"crossref","first-page":"e54114","DOI":"10.1371\/journal.pone.0054114","article-title":"DNA methylation in the malignant transformation of meningiomas","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-004-0911-6","article-title":"DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q","volume":"108","author":"Bello","year":"2004","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","article-title":"Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma","volume":"133","author":"Olar","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jnen\/nlx008","article-title":"Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics","volume":"76","author":"Boulagnon-Rombi","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-015-1459-3","article-title":"Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen","volume":"130","author":"Menke","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.path.2020.02.002_bib69","first-page":"1312","article-title":"Progesterone receptor expression in meningiomas","volume":"53","author":"Carroll","year":"1993","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.path.2020.02.002_bib70","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/neuonc\/noy057","article-title":"Meningioma transcription factors link cell lineage with systemic metabolic cues","volume":"20","author":"Du","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib71","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jcp.41.3.314","article-title":"Immunocytochemical study of the cellular immune response in meningiomas","volume":"41","author":"Rossi","year":"1988","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0303-8467(99)00052-9","article-title":"Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma","volume":"101","author":"Asai","year":"1999","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.path.2020.02.002_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2015.07.019","article-title":"Tumor infiltrating immune cells in gliomas and meningiomas","volume":"53","author":"Domingues","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.path.2020.02.002_bib74","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","article-title":"Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas","volume":"181","author":"Domingues","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"10","key":"10.1016\/j.path.2020.02.002_bib75","doi-asserted-by":"crossref","first-page":"e74798","DOI":"10.1371\/journal.pone.0074798","article-title":"Association between inflammatory infiltrates and isolated monosomy 22\/del(22q) in meningiomas","volume":"8","author":"Domingues","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.path.2020.02.002_bib76","doi-asserted-by":"crossref","first-page":"e1440931","DOI":"10.1080\/2162402X.2018.1440931","article-title":"Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma","volume":"7","author":"Pinton","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2990.2008.00960.x","article-title":"The microglial\/macrophagic response at the tumour-brain border of invasive meningiomas","volume":"35","author":"Grund","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11060-016-2256-0","article-title":"Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma","volume":"130","author":"Han","year":"2016","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.path.2020.02.002_bib79","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.18632\/oncotarget.3082","article-title":"Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma","volume":"6","author":"Du","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.path.2020.02.002_bib80","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/neuonc\/not110","article-title":"The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells","volume":"15","author":"Fang","year":"2013","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib81","doi-asserted-by":"crossref","first-page":"e1512943","DOI":"10.1080\/2162402X.2018.1512943","article-title":"Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma","volume":"8","author":"Proctor","year":"2019","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-019-0690-x","article-title":"Transcriptome signatures associated with meningioma progression","volume":"7","author":"Viaene","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"suppl_6","key":"10.1016\/j.path.2020.02.002_bib83","doi-asserted-by":"crossref","first-page":"vi100","DOI":"10.1093\/neuonc\/nox168.410","article-title":"GENE-37. Pathway analysis of radiation-induced meningiomas reveals that tumours with NF2-fusion have upregulation of inflammatory pathways","volume":"19","author":"Suppiah","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"S3","key":"10.1016\/j.path.2020.02.002_bib84","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1017\/cjn.2018.307","article-title":"56 unique immune microenvironment in NF2-fusion positive radiation induced meningiomas","volume":"45","author":"Suppiah","year":"2018","journal-title":"Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"},{"issue":"suppl_6","key":"10.1016\/j.path.2020.02.002_bib85","doi-asserted-by":"crossref","first-page":"vi259","DOI":"10.1093\/neuonc\/noy148.1076","article-title":"TMIC-17. Immune microenvironment of NF2-altered radiation-induced meningiomas","volume":"20","author":"Suppiah","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.path.2020.02.002_bib86","first-page":"525444","article-title":"Skull base meningiomas have a distinct immune landscape","author":"Zador","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.path.2020.02.002_bib87","series-title":"WHO classification of tumours of soft tissue and bone. World Health Organization classification of tumours","first-page":"468","author":"Fletcher","year":"2013"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib88","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0046-8177(91)90067-Y","article-title":"Hemangiopericytoma of the central nervous system: a review of 94 cases","volume":"22","author":"Mena","year":"1991","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/2010.6.JNS091660","article-title":"Hemangiopericytoma: long-term outcome revisited. Clinical article","volume":"114","author":"Schiariti","year":"2011","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.path.2020.02.002_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2559.2005.02290.x","article-title":"Solitary fibrous tumour and haemangiopericytoma: evolution of a concept","volume":"48","author":"Gengler","year":"2006","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib91","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/cncr.10328","article-title":"Clinicopathologic correlates of solitary fibrous tumors","volume":"94","author":"Gold","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib92","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1750-3639.2011.00552.x","article-title":"Solitary fibrous tumors and hemangiopericytomas of the meninges: overlapping pathological features and common prognostic factors suggest the same spectrum of tumors","volume":"22","author":"Bouvier","year":"2012","journal-title":"Brain Pathol"},{"issue":"9","key":"10.1016\/j.path.2020.02.002_bib93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","article-title":"Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model","volume":"25","author":"Demicco","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.path.2020.02.002_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.path.2020.02.002_bib96","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/gcc.22083","article-title":"Comprehensive genetic analysis identifies a pathognomonic NAB2\/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor","volume":"52","author":"Mohajeri","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib97","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.02.002_bib98","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5858\/arpa.2016-0570-RS","article-title":"Dedifferentiated solitary fibrous tumor: a concise review","volume":"142","author":"Olson","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2020.02.002_bib99","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ajpath.2013.12.016","article-title":"Solitary fibrous tumors\/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features","volume":"184","author":"Barthelmess","year":"2014","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.path.2020.02.002_bib100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/PAS.0000000000000625","article-title":"Analysis of NAB2-STAT6 gene fusion in 17 cases of meningeal solitary fibrous tumor\/hemangiopericytoma: review of the literature","volume":"40","author":"Yuzawa","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.02.002_bib101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.humpath.2014.11.018","article-title":"Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential","volume":"46","author":"Akaike","year":"2015","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.path.2020.02.002_bib102","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/modpathol.2016.126","article-title":"TERT promoter mutations and prognosis in solitary fibrous tumor","volume":"29","author":"Bahrami","year":"2016","journal-title":"Mod Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:58Z","timestamp":1761748798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918120300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1875918120300088"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.02.002","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Advances in Central Nervous System Mesenchymal Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}